The Discounted Cash Flow (DCF) valuation of Repligen Corp (RGEN) is (8.09) USD. With the latest stock price at 145.84 USD, the upside of Repligen Corp based on DCF is -105.5%.
Based on the latest price of 145.84 USD and our DCF valuation, Repligen Corp (RGEN) is a sell. selling RGEN stocks now will result in a potential gain of 105.5%.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| WACC / Discount Rate | 6.9% - 9.2% | 8.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (19.23) - (4.71) | (8.09) |
| Upside | -113.2% - -103.2% | -105.5% |